MedTrace Logo

"Volatile Anesthetic Protection Of Renal Transplants: VAPOR-1-trail

NCT01248871 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-04-18

No results posted yet for this study

Summary

To compare the renal protective properties of two currently used anaesthetic techniques - a sevoflurane-remifentanil/sufentanil combination with a propofol-remifentanil/sufentanil combination for anaesthesia in patients undergoing living donor kidney donation/transplantation.

Conditions

  • Kidney Donation/Transplantation

Interventions

DRUG

procedure:sevoflurane-remifentanil/sufentanil

Active Comparator

DRUG

volatile agent only during reperfusion

Active Comparator

DRUG

propofol-remifentanil/sufentanil

Active Comparator

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • M.M.R.F Struys, Prof.dr. · University Medical Center Groningen

  • R,J. Ploeg, Prof.dr · University Medical Center Groningen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01248871 on ClinicalTrials.gov